Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 
 

Mayo/Myriad Life Sciences Tracker

Myriad Banner

The Mayo/Myriad Life Sciences Tracker provides a single source for significant decisions in which the patent eligibility of life science claims is addressed under Mayo or Myriad.  Our index of sampled cases is updated regularly and can be filtered on various parameters.  Although this page does not include every decision related to Mayo or Myriad, we strive to capture the most relevant informative decisions, and post new decisions as they are published.

Mayo and Myriad addressed the patent eligibility of subject matter related to natural products and laws of nature, and the outcomes of these cases have significantly changed the landscape for prosecutors and litigators in the life sciences industry.  Since these decisions, the USPTO has issued updated guidance for applicants seeking patent claims to diagnostic methods, biomarker detection, and other life sciences technologies.

NameDateCourtException CategorySignificantly MoreStatus
Genetic Veterinary Sciences v. LABOklin GmbH5/17/2018E.D. Va.Natural PhenomenonNo
Pernix Ireland Pain v. Alvogen Malta Operations5/15/2018D. Del.Law of NatureNot Decided
Vanda Pharmaceuticals v. West-Ward Pharmaceuticals International4/13/2018Fed. Cir.NoneNot DecidedValid
Kaneka Corporation v. Zhejiang Medicine4/5/2018C.D. Cal.Natural PhenomenonYes
Pacific Biosciences v. Oxford Nanopore3/22/2018D. Del.NoneNot DecidedValid
Exergen Corporation v. Kaz USA, Inc.3/8/2018Fed. Cir.Law of NatureYesValid
Cedars Sinai v. Quest Diagnostic2/27/2018C.D. Cal.Law of NatureNot Decided
Oxford Immunotec, Ltd. v. Qiagen, Inc.9/26/2017D. Mass.Law of Nature, Natural PhenomenonYesValid
Natural Alternatives v. Creative Compounds9/5/2017S.D. Cal.Law of Nature, Natural PhenomenonNo
Mallindrockt v. Praxair9/5/2017D. Del.Law of Nature, Natural PhenomenonNo
Athena Diagnostics, Inc. v. Mayo Collaborative Services, et al.8/4/2017D. Mass.Law of NatureNoInvalid
Momenta Pharmaceuticals v. Amphastar Pharmaceuticals7/21/2017D. Mass.Law of Nature, Abstract IdeaNot Decided
Natural Alternatives International Inc. v. Allmax Nutrition Inc.6/26/2017S.D. Cal.Law of Nature, Natural PhenomenonNoInvalid
The Cleveland Clinic Foundation v. True Health Diagnostics, LLC6/16/2017Fed. Cir.Law of Nature, Natural PhenomenonNoInvalid
Viveve Inc. v. Thermigen LLC4/20/2017E.D. Tex.NoneYesValid
Boehringer Ingleheim v. HEC Pharma12/7/2016D.N.J.Abstract IdeaNoInvalid
Vanda Pharmaceuticals, Inc. v. Roxane Laboratories, Inc.8/25/2016D. Del.Law of NatureYesValid
Idexx Laboratories Inc. v. Charles River Laboratories Inc.7/7/2016D. Del.Abstract IdeaYesValid
Rapid Litigation Management v. CellzDirect7/5/2016Fed. Cir.NoneYesValid
Genetic Technologies v. Merial4/8/2016Fed. Cir.Law of NatureNoInvalid
load more

What Are Mayo and Myriad?

In Mayo Collaborative Services v. Prometheus Labs., Inc., 132 S. Ct. 1289 (2012), the Supreme Court articulated a two-part analytical framework for determining whether a claim is patent-eligible under 35 U.S.C. § 101.  Mayo dealt with one of three long-established judicial exceptions to patentability under 35 U.S.C. § 101: laws of nature.  In Association for Molecular Pathology v. Myriad Genetics, 133 S.Ct. 2107 (2013), the Court expanded on Mayo to deal with a different judicial exception: natural phenomena (or “products of nature”).

Read more

Fish Resources

Other Resources